137 related articles for article (PubMed ID: 24491093)
1. The use of monoclonal antibodies to treat Castleman's disease.
Robey RC; Mletzko S; Colley C; Balachandran K; Bower M
Immunotherapy; 2014; 6(2):211-9. PubMed ID: 24491093
[TBL] [Abstract][Full Text] [Related]
2. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Carbone A; De Paoli P; Gloghini A; Vaccher E
Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
[TBL] [Abstract][Full Text] [Related]
3. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
4. Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions.
Bryant-Greenwood P; Sorbara L; Filie AC; Little R; Yarchoan R; Wilson W; Raffeld M; Abati A
Mod Pathol; 2003 Feb; 16(2):145-53. PubMed ID: 12591967
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy.
Cannon M; Cesarman E
Semin Oncol; 2000 Aug; 27(4):409-19. PubMed ID: 10950367
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
Viejo-Borbolla A; Schulz TF
AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated multicentric Castleman's disease.
Stebbing J; Pantanowitz L; Dayyani F; Sullivan RJ; Bower M; Dezube BJ
Am J Hematol; 2008 Jun; 83(6):498-503. PubMed ID: 18260115
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
Bower M; Newsom-Davis T; Naresh K; Merchant S; Lee B; Gazzard B; Stebbing J; Nelson M
J Clin Oncol; 2011 Jun; 29(18):2481-6. PubMed ID: 21555697
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
10. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
Deloose ST; Smit LA; Pals FT; Kersten MJ; van Noesel CJ; Pals ST
Leukemia; 2005 May; 19(5):851-5. PubMed ID: 15744337
[TBL] [Abstract][Full Text] [Related]
11. Primary effusion lymphoma in HIV-infected patients with multicentric Castleman's disease.
Ascoli V; Signoretti S; Onetti-Muda A; Pescarmona E; Della-Rocca C; Nardi F; Mastroianni CM; Gastaldi R; Pistilli A; Gaidano G; Carbone A; Lo-Coco F
J Pathol; 2001 Feb; 193(2):200-9. PubMed ID: 11180167
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
Cathomas G
Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
[TBL] [Abstract][Full Text] [Related]
14. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
16. Serous fluid cytology of multicentric Castleman's disease and other lymphoproliferative disorders associated with Kaposi sarcoma-associated herpes virus: a review with case reports.
Lobo C; Amin S; Ramsay A; Diss T; Kocjan G
Cytopathology; 2012 Apr; 23(2):76-85. PubMed ID: 21658135
[TBL] [Abstract][Full Text] [Related]
17. Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease.
Brousset P; Cesarman E; Meggetto F; Lamant L; Delsol G
Hum Pathol; 2001 Jan; 32(1):95-100. PubMed ID: 11172301
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Cesarman E; Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):54-66. PubMed ID: 9044510
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of Castleman's disease in Korea.
Kim JE; Kim CJ; Park IA; Kim WH; Seo JW; Jang JJ; Kim CW; Park SH; Lee HS; Chi JG; Kim YI; Ham EK
J Korean Med Sci; 2000 Aug; 15(4):393-8. PubMed ID: 10983686
[TBL] [Abstract][Full Text] [Related]
20. Novel monoclonal antibodies for identification of multicentric Castleman's disease; Kaposi's sarcoma-associated herpesvirus-encoded vMIP-I and vMIP-II.
Nakano K; Katano H; Tadagaki K; Sato Y; Ohsaki E; Mori Y; Yamanishi K; Ueda K
Virology; 2012 Apr; 425(2):95-102. PubMed ID: 22297135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
